Results 31 to 40 of about 21,804,485 (185)
A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. [PDF]
Dissolution research started to develop about 100 years ago as a field of physical chemistry and since then important progress has been made. However, explicit interest in drug related dissolution has grown only since the realisation that dissolution is ...
Macheras, Panos +7 more
core +8 more sources
Biopharmaceutics Classification System (BCS)-based biowaiver are meant to reduce the need for establishing in vivo bioequivalence in situations where in vitro data may be considered to provide a reasonable estimate of the relative in vivo performance of two products. The BCS is a scientific approach designed to predict medicinal absorption based ...
Nidhi Sagar +4 more
openaire +2 more sources
Biopharmaceutics drug disposition classification system
The Biopharmaceutics Drug Disposition Classification System (BDDCS) is a revision of the Biopharmaceutics (or Biopharmaceutical) Classification System (BCS) that may be useful to predict routes of elimination and to foresee the effects of absorptive and ...
Bellera, Carolina Leticia, Talevi, Alan
core +1 more source
Comparing Multi-Label Classification Methods for Provisional Biopharmaceutics Class Prediction. [PDF]
The biopharmaceutical classification system (BCS) is now well established and utilized for the development and biowaivers of immediate oral dosage forms. The prediction of BCS class can be carried out using multilabel classification.
Taravat Ghafourian +8 more
core +1 more source
The present study was aimed to formulate, optimize and evaluate the Tetrabenazine nanocoacervates. Tetrabenazine is a BCS ClassIV drug with low solubility and low permeability, hence nanocoacervates were prepared to improve its solubility and permeability.
S. Haseena Begum +3 more
openaire +1 more source
Impact of Crystal Habit on the Dissolution Rate and In Vivo Pharmacokinetics of Sorafenib Tosylate
The dissolution rate is the rate-limiting step for Biopharmaceutics Classification System (BCS) class II drugs to enhance their in vivo pharmacokinetic behaviors. There are some factors affecting the dissolution rate, such as polymorphism, particle size,
Chi Uyen Phan +4 more
doaj +1 more source
Towards the development of a paediatric biopharmaceutics classification system : results of a survey of experts [PDF]
The aim of this research survey was to understand current global thinking around the need for and development of a paediatric biopharmaceutics classification system (pBCS) to be used for the development of paediatric medicines and regulatory purposes (e ...
Turner, Roy +6 more
core +4 more sources
Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap to Improve Their Therapeutic Index [PDF]
Purpose: Biopharmaceutics classification system (BCS) class IV compounds, exhibits least oral bioavailability, low solubility and intestinal permeability among all pharmaceutical classes of drugs.
Sachin Kumar +3 more
doaj +1 more source
Biopharmaceutics, in connection with pharmacokinetics, is the field that investigates and describes everything that happens with a medicinal product and the active substance between the moment of administration, the moment it exerts its action and the ...
Lagarce, Frederic +3 more
core +1 more source
In vitro‐in vivo correlation (IVIVC) allows prediction of the in vivo performance of a pharmaceutical product based on its in vitro drug release profiles and can be used to reduce the number of bioequivalence (BE) studies during product development, and ...
Jiaying Wang +7 more
doaj +1 more source

